PP, X., YQ, S., JZ, S., QQ, C., H, Z., LL, Z., . . . WL, Z. (2026). Tucidinostat Plus R-CHOP vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma: A Randomized Clinical Trial. JAMA, 335(19), 1684. https://doi.org/10.1001/jama.2026.4199
Chicago Style (17th ed.) CitationPP, Xu, et al. "Tucidinostat Plus R-CHOP Vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma: A Randomized Clinical Trial." JAMA 335, no. 19 (2026): 1684. https://doi.org/10.1001/jama.2026.4199.
MLA (9th ed.) CitationPP, Xu, et al. "Tucidinostat Plus R-CHOP Vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma: A Randomized Clinical Trial." JAMA, vol. 335, no. 19, 2026, p. 1684, https://doi.org/10.1001/jama.2026.4199.
Warning: These citations may not always be 100% accurate.